{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T19:07:44Z","timestamp":1775848064902,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nantong Health and Wellness Committee","award":["MS2022069"],"award-info":[{"award-number":["MS2022069"]}]},{"name":"Nantong Health and Wellness Committee","award":["MS2023070"],"award-info":[{"award-number":["MS2023070"]}]},{"name":"Nantong Science and Technology Bureau","award":["JC22022025"],"award-info":[{"award-number":["JC22022025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78481-5","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T07:04:09Z","timestamp":1730790249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploration on the construction of a bladder cancer prognostic model based on disulfidptosis-related lncRNAs and its clinical significance"],"prefix":"10.1038","volume":"14","author":[{"given":"Xian-Cun","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"78481_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"78481_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LM van Hoogstraten","year":"2023","unstructured":"van Hoogstraten, L. M. et al. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat. Rev. Clin. Oncol. 20, 287\u2013304 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"78481_CR3","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/jjco\/hyaa155","volume":"50","author":"T Kimura","year":"2020","unstructured":"Kimura, T. et al. Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future. Jpn. J. Clin. Oncol. 50, 1097\u20131107 (2020).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"78481_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2174\/1874467208666150716120945","volume":"9","author":"M Vasekar","year":"2016","unstructured":"Vasekar, M., Degraff, D. & Joshi, M. Immunotherapy in bladder cancer. Curr. Mol. Pharmacol. 9, 242\u2013251 (2016).","journal-title":"Curr. Mol. Pharmacol."},{"key":"78481_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2016.20324","volume":"317","author":"AH Mokdad","year":"2017","unstructured":"Mokdad, A. H. et al. Trends and patterns of disparities in cancer mortality among US counties, 1980\u20132014. JAMA 317, 388\u2013406 (2017).","journal-title":"JAMA"},{"key":"78481_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat. Cell. Biol. 25, 404\u2013414 (2023).","journal-title":"Nat. Cell. Biol."},{"key":"78481_CR7","doi-asserted-by":"publisher","first-page":"107402","DOI":"10.1016\/j.compbiomed.2023.107402","volume":"165","author":"J Huang","year":"2023","unstructured":"Huang, J. et al. Identification of a disulfidptosis-related genes signature for prognostic implication in lung adenocarcinoma. Comput. Biol. Med. 165, 107402 (2023).","journal-title":"Comput. Biol. Med."},{"key":"78481_CR8","doi-asserted-by":"publisher","first-page":"1204338","DOI":"10.3389\/fimmu.2023.1204338","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma. Front. Immunol. 14, 1204338 (2023).","journal-title":"Front. Immunol."},{"key":"78481_CR9","doi-asserted-by":"publisher","first-page":"1205250","DOI":"10.3389\/fimmu.2023.1205250","volume":"14","author":"K Xu","year":"2023","unstructured":"Xu, K. et al. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis. Front. Immunol. 14, 1205250 (2023).","journal-title":"Front. Immunol."},{"key":"78481_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12935-023-03065-8","volume":"23","author":"W Xue","year":"2023","unstructured":"Xue, W. et al. Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma. Cancer Cell. Int. 23, 218 (2023).","journal-title":"Cancer Cell. Int."},{"key":"78481_CR11","doi-asserted-by":"publisher","first-page":"111158","DOI":"10.1016\/j.biopha.2020.111158","volume":"134","author":"C Xing","year":"2021","unstructured":"Xing, C., Sun, S., Yue, Z-Q. & Bai, F. Role of lncRNA LUCAT1 in cancer. Biomed. Pharmacother. 134, 111158 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"78481_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10555-017-9713-x","volume":"37","author":"Q Huang","year":"2018","unstructured":"Huang, Q., Yan, J. & Agami, R. Long non-coding RNAs in metastasis. Cancer Metastasis Rev. 37, 75\u201381 (2018).","journal-title":"Cancer Metastasis Rev."},{"key":"78481_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"Y-T Tan","year":"2021","unstructured":"Tan, Y-T. et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun. 41, 109\u2013120 (2021).","journal-title":"Cancer Commun."},{"key":"78481_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01188-4","volume":"19","author":"Z Huang","year":"2020","unstructured":"Huang, Z., Zhou, J-K., Peng, Y., He, W. & Huang, C. The role of long noncoding RNAs in hepatocellular carcinoma. Mol. Cancer 19, 1\u201318 (2020).","journal-title":"Mol. Cancer"},{"key":"78481_CR15","doi-asserted-by":"publisher","first-page":"14421","DOI":"10.1038\/ncomms14421","volume":"8","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. Recurrently deregulated lncRNAs in hepatocellular carcinoma. Nat. Commun. 8, 14421 (2017).","journal-title":"Nat. Commun."},{"key":"78481_CR16","doi-asserted-by":"publisher","first-page":"1120827","DOI":"10.3389\/fgene.2023.1120827","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma. Front. Genet. 14, 1120827 (2023).","journal-title":"Front. Genet."},{"key":"78481_CR17","doi-asserted-by":"publisher","first-page":"110368","DOI":"10.1016\/j.intimp.2023.110368","volume":"120","author":"T Wang","year":"2023","unstructured":"Wang, T. et al. Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile. Int. Immunopharmacol. 120, 110368 (2023).","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"78481_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"78481_CR19","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"78481_CR20","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51 (D1), D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"78481_CR21","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1089\/ars.2020.8151","volume":"33","author":"CG Miller","year":"2020","unstructured":"Miller, C. G. & Schmidt, E. E. Sulfur metabolism under stress. Antioxid. Redox Signal. 33, 1158\u20131173 (2020).","journal-title":"Antioxid. Redox Signal."},{"key":"78481_CR22","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1089\/ars.2017.7224","volume":"30","author":"RK Mistry","year":"2019","unstructured":"Mistry, R. K. & Brewer, A. C. Redox-dependent regulation of sulfur metabolism in biomolecules: Implications for cardiovascular health. Antioxid. Redox Signal. 30, 972\u2013991 (2019).","journal-title":"Antioxid. Redox Signal."},{"key":"78481_CR23","doi-asserted-by":"publisher","first-page":"BSR20180992","DOI":"10.1042\/BSR20180992","volume":"39","author":"X Xu","year":"2019","unstructured":"Xu, X., Lai, Y. & Hua, Z-C. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci. Rep. 39, BSR20180992 (2019).","journal-title":"Biosci. Rep."},{"key":"78481_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li, J. et al. Ferroptosis: past, present and future. Cell. Death Dis. 11, 88 (2020).","journal-title":"Cell. Death Dis."},{"key":"78481_CR25","doi-asserted-by":"publisher","first-page":"109595","DOI":"10.1016\/j.biopha.2019.109595","volume":"121","author":"Y Fang","year":"2020","unstructured":"Fang, Y. et al. Pyroptosis: a new frontier in cancer. Biomed. Pharmacother. 121, 109595 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"78481_CR26","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254\u20131261 (2022).","journal-title":"Science"},{"key":"78481_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41420-020-00349-0","volume":"6","author":"M Jiang","year":"2020","unstructured":"Jiang, M., Qi, L., Li, L. & Li, Y. The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell. Death Discov. 6, 112 (2020).","journal-title":"Cell. Death Discov."},{"key":"78481_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou, Y. et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J. Hematol. Oncol. 12, 34 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"78481_CR29","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.7314\/APJCP.2015.16.6.2129","volume":"16","author":"S Goldar","year":"2015","unstructured":"Goldar, S., Khaniani, M. S., Derakhshan, S. M. & Baradaran, B. Molecular mechanisms of apoptosis and roles in Cancer Development and Treatment. Asian Pac. J. Cancer Prev. 16, 2129\u20132144 (2015).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"78481_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-020-1143-7","volume":"19","author":"Y Zhan","year":"2020","unstructured":"Zhan, Y. et al. Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2. Mol. Cancer 19, 25 (2020).","journal-title":"Mol. Cancer"},{"key":"78481_CR31","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1172\/JCI96218","volume":"128","author":"W He","year":"2018","unstructured":"He, W. et al. Long noncoding RNA BLACAT2 promotes bladder cancer\u2013associated lymphangiogenesis and lymphatic metastasis. J. Clin. Investig. 128, 861\u2013875 (2018).","journal-title":"J. Clin. Investig."},{"key":"78481_CR32","doi-asserted-by":"publisher","first-page":"803355","DOI":"10.3389\/fimmu.2022.803355","volume":"13","author":"H Lu","year":"2022","unstructured":"Lu, H., Wu, J., Liang, L., Wang, X. & Cai, H. Identifying a novel defined pyroptosis-associated long noncoding RNA signature contributes to predicting prognosis and tumor microenvironment of bladder cancer. Front. Immunol. 13, 803355 (2022).","journal-title":"Front. Immunol."},{"key":"78481_CR33","doi-asserted-by":"publisher","first-page":"10217","DOI":"10.1007\/s00432-023-04886-w","volume":"149","author":"Y-F Sun","year":"2023","unstructured":"Sun, Y-F., Chen, L., Xia, Q-J. & Wang, T-H. Identification of necroptosis-related long non-coding RNAs prognostic signature and the crucial lncRNA in bladder cancer. J. Cancer Res. Clin. Oncol. 149, 10217\u201310234 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"78481_CR34","doi-asserted-by":"publisher","first-page":"1027449","DOI":"10.3389\/fimmu.2022.1027449","volume":"13","author":"Y Bai","year":"2022","unstructured":"Bai, Y., Zhang, Q., Liu, F. & Quan, J. A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer. Front. Immunol. 13, 1027449 (2022).","journal-title":"Front. Immunol."},{"key":"78481_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.eururo.2021.09.028","volume":"81","author":"S Burdett","year":"2022","unstructured":"Burdett, S. et al. Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and Meta-analysis of individual participant data from randomised controlled trials. Eur. Urol. 81, 50\u201361 (2022).","journal-title":"Eur. Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78481-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78481-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78481-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T11:05:47Z","timestamp":1731063947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78481-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78481"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78481-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26751"}}